BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35274189)

  • 1. Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary.
    Magyari F; Virga I; Simon Z; Miltényi Z; Illés A; Kósa K; Ivánka T; Berecz R; Égerházi A; Illés Á
    Support Care Cancer; 2022 Jun; 30(6):5249-5258. PubMed ID: 35274189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Employment status and health related quality of life among Hodgkin-lymphoma survivors'- results based on data from a major treatment center in Hungary.
    Magyari F; Kósa K; Berecz R; Illés A; Miltényi Z; Simon Z; Illés Á
    Health Qual Life Outcomes; 2017 Sep; 15(1):180. PubMed ID: 28927453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients.
    Juríčková V; Fayette D; Jonáš J; Fajnerová I; Kozák T; Horáček J
    Curr Oncol; 2023 Oct; 30(10):9028-9038. PubMed ID: 37887552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive function and CNS integrity in adult survivors of childhood hodgkin lymphoma.
    Krull KR; Sabin ND; Reddick WE; Zhu L; Armstrong GT; Green DM; Arevalo AR; Krasin MJ; Srivastava DK; Robison LL; Hudson MM
    J Clin Oncol; 2012 Oct; 30(29):3618-24. PubMed ID: 22949149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in hodgkin lymphoma survivors.
    Trachtenberg E; Mashiach T; Ben Hayun R; Tadmor T; Fisher T; Aharon-Peretz J; Dann EJ
    Br J Haematol; 2018 Sep; 182(5):670-678. PubMed ID: 29974933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis.
    Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment associated with Hodgkin's lymphoma and chemotherapy.
    Fayette D; Juríčková V; Kozák T; Mociková H; Gaherová L; Fajnerová I; Horáček J
    Neurosci Lett; 2023 Feb; 797():137082. PubMed ID: 36693557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors.
    Mariegaard J; Wenstrup J; Lim KZM; Bidstrup PE; von Heymann A; Johansen C; Knudsen GM; Law I; Specht L; Stenbæk DS
    Support Care Cancer; 2021 Jun; 29(6):3319-3328. PubMed ID: 33118105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests.
    Giedraitiene N; Kaubrys G
    Front Neurol; 2019; 10():572. PubMed ID: 31214108
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the Cambridge Automated Neuropsychological Test Battery (CANTAB) Distinguish Between Cognitive Domains in Healthy Older Adults?
    Lenehan ME; Summers MJ; Saunders NL; Summers JJ; Vickers JC
    Assessment; 2016 Apr; 23(2):163-72. PubMed ID: 25882162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors.
    Gaynor AM; Ahsan A; Jung D; Schofield E; Li Y; Ryan E; Ahles TA; Root JC
    J Cancer Surviv; 2024 Apr; 18(2):466-478. PubMed ID: 35939254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study.
    Huisman J; Aukema EJ; Deijen JB; van Coeverden SC; Kaspers GJ; van der Pal HJ; Delemarre-van de Waal HA
    BMC Pediatr; 2008 Jun; 8():25. PubMed ID: 18570650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of neuropsychological performance in Mexico City youth using the Cambridge Neuropsychological Test Automated Battery (CANTAB).
    Green R; Till C; Al-Hakeem H; Cribbie R; Téllez-Rojo MM; Osorio E; Hu H; Schnaas L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):246-256. PubMed ID: 30336715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.
    Castellino SM; Ullrich NJ; Whelen MJ; Lange BJ
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25080574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validation of a new online cognitive assessment tool: The MyCognition Quotient.
    Domen AC; van de Weijer SCF; Jaspers MW; Denys D; Nieman DH
    Int J Methods Psychiatr Res; 2019 Sep; 28(3):e1775. PubMed ID: 30761648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do classical and computerized cognitive tests have equal intrarater reliability in myotonic dystrophy type 1?
    Fortin J; Côté I; Gagnon C; Gallais B
    Neuromuscul Disord; 2023 Jun; 33(6):490-497. PubMed ID: 37209494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual memory profiling with CANTAB in mild cognitive impairment (MCI) subtypes.
    Juncos-Rabadán O; Facal D; Pereiro AX; Lojo-Seoane C
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1040-8. PubMed ID: 24633821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between depression and cognitive decline in sclerosis multiplex patients].
    Hegedüs K; Kárpáti J; Szombathelyi É; Simó M
    Neuropsychopharmacol Hung; 2015 Mar; 17(1):31-6. PubMed ID: 25935381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.